Researcher.Life Logo

Clinical Immunology : Impact Factor & More

eISSN: 1521-7035pISSN: 1521-6616

Key Metrics

CiteScore
10.4
Impact Factor
5 - 10
SNIP
1.43
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Clinical Immunology

Clinical Immunology Journal Specifications

Overview
Publisher ACADEMIC PRESS INC ELSEVIER SCIENCE
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1999
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Clinical Immunology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical Immunology

Vamifeport, a clinical stage oral ferroportin inhibitor, alleviates murine lupus nephritis: A pilot study.
  • 1 Jun 2026
  • Clinical immunology (Orlando, Fla.)
Efficacy and safety of telitacicept for myasthenia gravis in real-world practice and exploratory outcomes in the elderly subgroup.
  • 1 Jun 2026
  • Clinical immunology (Orlando, Fla.)
PLK2 facilitates Mycobacterium tuberculosis clearance via p38 MAPK-mediated ROS production.
  • 1 Jun 2026
  • Clinical immunology (Orlando, Fla.)
NF-κB1 haploinsufficiency due to a novel c.104delT variant in two patients with common variable immunodeficiency.
  • 1 Jun 2026
  • Clinical immunology (Orlando, Fla.)
Reconsidering the nosology of CYBB S333Y-associated adult-onset mycobacterial susceptibility.
  • 1 Jun 2026
  • Clinical immunology (Orlando, Fla.)
Relationship between repertoire diversity of B cell receptor immunoglobulin G heavy chain and infectious complications caused by encapsulated bacteria after allogeneic hematopoietic cell transplantation.
  • 1 Jun 2026
  • Clinical immunology (Orlando, Fla.)
Vamifeport, a clinical stage oral ferroportin inhibitor, alleviates murine lupus nephritis: A pilot study.
  • 1 Jun 2026
  • Clinical immunology (Orlando, Fla.)
Efficacy and safety of telitacicept for myasthenia gravis in real-world practice and exploratory outcomes in the elderly subgroup.
  • 1 Jun 2026
  • Clinical immunology (Orlando, Fla.)
PLK2 facilitates Mycobacterium tuberculosis clearance via p38 MAPK-mediated ROS production.
  • 1 Jun 2026
  • Clinical immunology (Orlando, Fla.)
NF-κB1 haploinsufficiency due to a novel c.104delT variant in two patients with common variable immunodeficiency.
  • 1 Jun 2026
  • Clinical immunology (Orlando, Fla.)
Reconsidering the nosology of CYBB S333Y-associated adult-onset mycobacterial susceptibility.
  • 1 Jun 2026
  • Clinical immunology (Orlando, Fla.)
Relationship between repertoire diversity of B cell receptor immunoglobulin G heavy chain and infectious complications caused by encapsulated bacteria after allogeneic hematopoietic cell transplantation.
  • 1 Jun 2026
  • Clinical immunology (Orlando, Fla.)

FAQs on Clinical Immunology